Joey New York, Inc. (OTCBB:JOEY) gained volume of 29,252.00 shares and the average volume of the stock remained 26,858.00 shares. The 52 week range of the stock remained $0.02 – $1.05 and today’s day range was $0.09 – $0.11. The stock opened the session at $0.09 but then moved to $0.107, at recent check. At that price, the stock was showing a positive performance of +18.89%.
Joey New York, Inc., through its subsidiary, RAR Beauty, LLC, manufactures and markets natural skin care and beauty products in the United States and Internationally. The company operates through The LABB, Aesthetic Beauty Bar; and Joey New York Cosmetics divisions. The LABB, Aesthetic Beauty Bar division provides injectable services, which eliminate unwanted wrinkles by performing Botox and filler injections. The company offers its products under the Joey New York brand. It offers its products through retailers, professional salons, spas, and beauty Websites.
Akers Biosciences, Inc. (NASDAQ:AKER) was trading with a volume of 2.15 million shares versus the average volume of the stock 8.11 million shares. The stock increased +6.16% and was recently trading at $0.41. The market capitalization of the stock remained 36.70 million. The EPS of the stock was -0.57.
Akers Biosciences, Inc. (AKER), together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States, the People’s Republic of China, and internationally. The company’s marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor ketosis; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness. Its marketed products also include PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests for Heparin/PF4 antibodies to detect an allergy to the used blood thinner, Heparin; seraSTAT, a rapid blood cell separator; Tri-Cholesterol ?Check’, a rapid test for total and high density lipoprotein cholesterol and estimates low density lipo protein; and BreathScan OxiCHek, a breath test for oxidative stress using the Lync reader and digital app.
In the current trading day, Ambow Education Holding Ltd. (NYSE:AMBO) increased +79.27% to move at $7.35. The volume of the stock was 2.00 million shares and the average volume remained 130.85K shares. The stock, at last check, has the day price range of $4.25 – $8.00. The market capitalization was recorded at 128.92 million.
Ambow Education Holding Ltd. (AMBO) on June 5, 2018 announced the closing of its previously announced public offering of 1,800,000 American Depositary Shares (“ADSs”), each representing two (2) of its Class A Ordinary Shares, at US$4.25 per ADS.
Gross proceeds to the Company from this offering are US$7,650,000, before deducting underwriting discounts, commissions and other related expenses. In addition, the Company has granted the underwriter a 45-day option to purchase up to an aggregate of 270,000 additional ADSs at the public offering price, less underwriting discounts and commissions, to cover over-allotments.